A comprehensive scientific review published in Health Nanotechnology examines how the convergence of artificial intelligence and nanoscale science is reshaping the discovery, synthesis, characterization, and biomedical application of functional nanomaterials. Nanotechnology centers on the precise understanding and manipulation of matter at dimensions between 1 and 100 nanometers, where high surface-to-volume ratios and quantum confinement phenomena yield physicochemical behaviors distinct from bulk materials. Conventional fabrication workflows have historically relied on trial-and-error experimentation across multidimensional parameter spaces, including precursor concentrations, reaction temperatures, pH levels, synthesis times, and capping agents. In parallel, advanced computational methods—ranging from classical machine learning algorithms to deep artificial neural networks—have emerged as powerful mechanisms for deciphering nonlinear structure-property relationships and optimizing multidimensional problems. By systematically analyzing the state of AI-driven nanoscience, the review outlines how computational modeling accelerates research while identifying the foundational data limitations, reproducibility challenges, and regulatory bottlenecks that currently prevent laboratory demonstrations from translating into widespread clinical and industrial applications.
The methodological landscape of machine learning in nanoscience encompasses distinct algorithms whose suitability depends directly on dataset size, problem dimensionality, and interpretability requirements. Artificial neural networks capture complex nonlinear interactions between synthesis variables and particle properties, such as hydrodynamic diameter and drug encapsulation efficiency, but their black-box architectures present interpretability challenges. Random forest models, constructed from ensembles of decision trees, offer robust performance on small to medium-sized heterogeneous datasets and provide feature-importance metrics that identify critical formulation drivers. Support vector machines effectively navigate high-dimensional feature spaces with limited sample sizes, making them useful for nanoparticle size estimation and surface nanotopography analysis. Gaussian process regression functions as a probabilistic technique providing both continuous predictions and explicit uncertainty estimates, establishing it as a primary surrogate model for Bayesian optimization workflows. Specialized deep learning architectures extend these analytical capabilities to high-dimensional structured inputs: convolutional neural networks process spatial imaging data, recurrent neural networks and long short-term memory networks analyze sequential drug release profiles, generative models facilitate structural inverse design, and graph neural networks map atomic topologies directly to macroscopic material properties.
In the domain of nanomaterial discovery and forward property prediction, machine learning methods increasingly serve as high-throughput surrogate models that complement density functional theory calculations and classical electromagnetic simulations. High-throughput computational screening frameworks integrated with machine learning enable the systematic identification of potentially exfoliable two-dimensional materials from known layered structures, drastically reducing first-principles computational costs. Graph neural networks, specifically crystal graph architectures, accurately forecast formation energies, electronic band gaps, and structure-dependent behaviors directly from crystal coordinates. When paired with density functional theory adsorption datasets, data-driven algorithms prioritize promising bimetallic catalyst candidates for critical electrochemical reactions, including the oxygen reduction reaction and carbon dioxide reduction. Beyond catalyst discovery, convolutional neural networks predict the optical responses of plasmonic nanostructures and extract underlying structural geometries from measured optical spectra. Machine learning models also predict size-dependent semiconductor quantum dot bandgaps, thermal conductivities, and mechanical properties, while explainable techniques like Shapley Additive Explanations quantify individual feature contributions to enhance physical plausibility.
Generative modeling architectures represent a fundamental paradigm shift by enabling the inverse design of functional nanostructures, moving from desired target performance metrics directly to candidate geometric configurations. Rather than evaluating pre-existing structures iteratively, generative adversarial networks, variational autoencoders, and large language models explore continuous multidimensional latent representations to propose novel nanostructures. In nanophotonics and metasurface engineering, generative adversarial networks learn mapping functions between structural geometries and optical spectra, generating candidate designs that fulfill predefined plasmonic resonances or target bandgaps without repeated Maxwell equation simulations. Variational autoencoders provide smooth latent spaces that permit systematic interpolation between candidate materials, assisting in the targeted optimization of complex nanostructures. Additionally, large language models assist researchers through automated literature mining, scientific information extraction, hypothesis generation, and experimental synthesis planning. Despite these algorithmic successes, published inverse design studies remain predominantly proof-of-concept investigations conducted on narrow, single-laboratory datasets, underscoring the urgent necessity for standardized benchmarking suites, open-access repositories, and rigorous external validation across independently synthesized materials.
Machine learning has significantly refined nanoparticle synthesis workflows by modeling complex multi-parameter interactions and enabling autonomous laboratory experimentation. Standard regression architectures, including random forests and neural networks, map formulation variables—such as polymer loading, surfactant ratios, solvent mixtures, pH, and mixing kinetics—to physical attributes like polydispersity and colloidal stability. Building upon these models, single- and multi-objective Bayesian optimization frameworks utilize acquisition functions to balance exploration of unmeasured conditions with exploitation of favorable formulations, generating Pareto-optimal frontiers for competing parameters such as encapsulation yield and particle size. This computational methodology reaches its physical manifestation in self-driving laboratories, which integrate robotic fluidics, automated inline characterization tools, and machine learning decision loops. Autonomous platforms, exemplified by systems developed for shape-programmable gold nanoparticles and the reinforcement-learning-guided AlphaFlow fluidic synthesizer, execute closed-loop cycles of synthesis, measurement, and model updating. Concurrently, machine learning models optimize green synthesis protocols utilizing biological phytochemical extracts, systematically tuning reaction conditions to replace hazardous reagents while sustaining nanomanufacturing yields.
In biomedical nanotechnology and precision medicine, machine learning models support the rational engineering of drug delivery carriers, cellular uptake forecasting, and patient-specific therapeutic platforms. Long short-term memory architectures capture the continuous kinetics of drug dissolution and release from polymeric nanocarriers, facilitating inverse formulation design tailored to produce zero-order or sustained release kinetics. Deep convolutional models analyzing high-content fluorescence microscopy achieve up to 92 percent accuracy in classifying nanoparticle cellular internalization under controlled in vitro conditions. Random forest models utilizing molecular weight, surface charge, and lipid solubility predict blood-brain barrier penetration with 88 percent accuracy, illustrating computational potential for neurodegenerative therapeutics. Furthermore, artificial neural networks trained on physicochemical properties predict the composition of the biomolecular protein corona that forms upon systemic exposure, aiding the design of long-circulating stealth nanocarriers. Looking toward personalized nanomedicine, conceptual frameworks propose integrating patient-derived genomic profiles, biopsy data, and biosensor inputs with deep reinforcement learning to adjust dosing dynamically, though substantial preclinical validation remains essential.
Predictive nanotoxicology leverages machine learning to forecast biological hazards, yet it faces notable hurdles stemming from biological complexity and heterogeneous toxicological endpoints. In benchmark evaluations, random forest models trained on diverse datasets of over 300 nanoparticles—including metal oxides, quantum dots, and carbon nanotubes—demonstrated approximately 85 percent accuracy in predicting in vitro cell viability, identifying surface functionalization and hydrodynamic dimensions as predominant determinants of cytotoxic response. However, toxicological outcomes span diverse biological mechanisms, including membrane disruption, oxidative stress generation, chromosomal aberrations, and immunogenic cytokine release, each requiring distinct experimental assays and feature representations. Because most existing predictive tools are trained on single cell-line assays over restricted 24-hour exposure intervals, models frequently fail when generalized across structurally distinct materials like lipid nanoparticles or when extrapolating from simplified in vitro assays to complex in vivo pharmacokinetics, organ accumulation, and systemic clearance pathways.
Nanoscale characterization and experimental data interpretation have advanced rapidly through deep learning frameworks applied to electron microscopy, scanning probe methods, and spectroscopy. In transmission electron microscopy, U-Net convolutional architectures have demonstrated superior particle segmentation capability, securing an overall accuracy of 96.65 percent and an F1 score of 0.909 across variable image sets, with performance reaching 98.95 percent on high-contrast micrographs before degrading to 92.76 percent on clustered or beam-damaged specimens. Shape classification networks, including ResNet-34 on scanning electron microscopy and AlexNet on scanning transmission electron microscopy, classify morphologies such as spheres, rods, triangles, and agglomerates with accuracies between 93 and 95 percent. In atomic force microscopy, convolutional networks correct thermal drift, scan-line noise, and tip broadening artefacts, while pix2pix conditional GANs enhance topographical contrast. Furthermore, convolutional networks extract defect densities and layer counts from Raman spectra of carbon nanomaterials, autoencoders compress hyperspectral energy-dispersive X-ray maps, and hybrid CNN-LSTM networks track dynamic nanoparticle trajectories through living cells.
Beyond solid-state nanomaterials and biomedical carriers, computational methodologies developed for nanofluid systems demonstrate the broad utility of physics-informed artificial intelligence in modeling nanoscale fluid transport and thermal dynamics. Dispersions of nanoscale particles within base fluids exhibit enhanced thermal conductivity and altered viscous properties critical for electronics cooling, advanced heat exchangers, and microfluidic technologies. Ensemble machine learning models routinely surpass empirical formulations in predicting nanofluid viscosity, thermal transport, and convective heat-transfer coefficients based on particle loading, size, temperature, and fluid chemistry. Crucially, physics-informed neural networks embed fundamental conservation equations—governing mass, momentum, and energy conservation—directly into neural training loss functions. This physics-constrained framework allows the accurate resolution of coupled transport equations at fractions of the computational cost demanded by traditional computational fluid dynamics simulations.
Despite substantial computational advances, the clinical and industrial translation of AI-enabled nanotechnology remains constrained by systemic data scarcity, algorithmic opacity, reproducibility shortfalls, and nascent regulatory structures. Nanotechnology datasets are typically small, frequently encompassing fewer than 1,000 data points collected under disparate experimental conditions, which elevates the risk of model overfitting and restricts generalizability across independent laboratories. To overcome these barriers, the scientific community is adopting FAIR data management principles alongside standardized reporting frameworks, such as the Minimum Information Reporting in Bio-Nano Experimental Literature guidelines and the Minimum Information About Nanomaterial framework. Addressing the black-box nature of deep neural networks requires expanding explainable AI tools, physics-informed architectures, and rigorous uncertainty quantification to generate calibrated confidence intervals for high-stakes healthcare applications. Concurrently, regulatory authorities such as the United States Food and Drug Administration and the European Medicines Agency are progressing governance models, though specific criteria for adaptive algorithms, continuously learning nanomedicines, and long-term nanosafety profiles remain under active development. Translating artificial intelligence from a proof-of-concept analytical tool into a reliable standard for autonomous materials manufacturing and precision medicine will ultimately require close, cross-disciplinary collaboration among computer scientists, materials engineers, biomedical researchers, and regulatory specialists.
Subject of Research: Review of artificial intelligence applications, methodologies, and translational challenges across nanotechnology and nanomedicine
Article Title: Artificial intelligence in nanotechnology: current applications and future perspectives
Article References: Majedi, A. (2026). Artificial intelligence in nanotechnology: current applications and future perspectives. Health Nanotechnology, 2(1), Article 16. https://doi.org/10.1186/s44301-026-00038-4
Image Credits: AI Generated
DOI: 10.1186/s44301-026-00038-4
Keywords: artificial intelligence, nanotechnology, nanomedicine, machine learning, deep learning, Bayesian optimization, self-driving laboratories, inverse design, generative adversarial networks, transmission electron microscopy, nanoparticle synthesis, drug delivery, nanotoxicology, physics-informed neural networks, materials informatics, MIRIBEL framework, reproducibility
News Source: Blake Davidson. (November 17, 2026). Artificial Intelligence Accelerates Nanotechnology but Faces Strict Experimental Validation Barriers. Scienmag.



